Genetix Biotherapeutics

Acquired

Genetic Medicine for Rare Diseases

Somerville, United States · Founded 1992

Founded
1992
Business Model
B2B
Acquisition Date
Jun 2025

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

Genetix Biotherapeutics (formerly bluebird bio) is a commercial-stage biotechnology company delivering genetic therapies for patients with sickle cell disease, beta-thalassemia, and cerebral adrenoleukodystrophy. Its FDA-approved, one-time administered therapies are based on a patient's own blood stem cells, modified outside the body to add working copies of an affected gene before being returned to restore normal gene function. Headquartered in Somerville, Massachusetts, the company traces its roots to 1992, when it was founded as Genetix Pharmaceuticals before rebranding to bluebird bio in 2010 and returning to the Genetix name in 2025.

Summary

Genetix Biotherapeutics is a Biotech company based in Somerville, United States, founded in 1992. Investors include The Carlyle Group.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Exit History

AcquisitionJun 2025

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Genetix Biotherapeutics on Indexed.vc
<a href="https://indexed.vc/companies/genetix-biotherapeutics"><img src="https://indexed.vc/api/badge/company/genetix-biotherapeutics" alt="Genetix Biotherapeutics on Indexed.vc" width="260" height="76" /></a>